J2KBIO제이투케이바이오
420570 · KOSDAQ · ₩420570 · 제이투케이바이오
₩7,300▼ ₩430 (5.56%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | ₩33B | ₩33B | ₩28B |
| Cost of sales | ₩20B | ₩20B | ₩17B |
| Gross profit | ₩13B | ₩13B | ₩12B |
| Operating income | ₩2.9B | ₩3.6B | ₩5.6B |
| Net income | ₩2.7B | −₩1.7B | ₩4.8B |
| Net income to shareholders | ₩2.7B | −₩1.7B | ₩4.8B |
Balance sheet
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Total assets | ₩38B | ₩36B | ₩22B |
| Current assets | ₩22B | ₩20B | ₩14B |
| Cash and equivalents | ₩12B | ₩7B | ₩3.9B |
| Total liabilities | ₩4.3B | ₩4.6B | ₩4.2B |
| Current liabilities | ₩3.1B | ₩2.5B | ₩3.7B |
| Borrowings | ₩400M | ₩1.3B | ₩1B |
| Total equity | ₩34B | ₩31B | ₩18B |
| Shareholders' equity | ₩34B | ₩31B | ₩18B |
Cash flow
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Cash from operations | ₩2B | ₩6.9B | ₩3.3B |
| Free cash flow | ₩2B | ₩6.9B | ₩3.3B |
| Dividends paid | ₩1.1B | — | ₩240M |
Consolidated where available. Amounts in won.
Also known as: J2KBIO / 제이투케이바이오 / 420570 / KRX:420570
Source: KRX statistical information